Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Tumour-intrinsic PDL1 signals regulate the Chk2 DNA damage response in cancer cells and mediate resistance to Chk1 inhibitors.
Journal: Molecular cancer
Published: February 07, 2024
A novel type-2 innate lymphoid cell-based immunotherapy for cancer.
Journal: Frontiers in immunology
Published: October 10, 2023
A binary self-amplifying expression platform enabling lipid nanoparticle-free vaccines and nanomedicines.
Journal: Nature communications
Published: May 03, 2023
Outside-in signaling through the major histocompatibility complex class-I cytoplasmic tail modulates glutamate receptor expression in neurons.
Journal: Scientific reports
Published: March 16, 2023
Pharmacological tumor PDL1 depletion with chlorambucil treats ovarian cancer and melanoma: improves antitumor immunity and renders anti-PDL1-resistant tumors anti-PDL1-sensitive through NK cell effects.
Journal: Journal for immunotherapy of cancer
Published: October 18, 2022
Specific cannabinoids revive adaptive immunity by reversing immune evasion mechanisms in metastatic tumours.
Journal: Frontiers in immunology
Published: June 30, 2022
Bladder cancer cell-intrinsic PD-L1 signals promote mTOR and autophagy activation that can be inhibited to improve cytotoxic chemotherapy.
Journal: Cancer medicine
Published: October 30, 2020
PKA Activates AMPK Through LKB1 Signaling in Follicular Thyroid Cancer.
Journal: Frontiers in endocrinology
Published: June 07, 2019
Mouse models of thyroid cancer: A 2015 update.
Journal: Molecular and cellular endocrinology
Published: April 10, 2015
Enhanced autoimmunity associated with induction of tumor immunity in thyroiditis-susceptible mice.
Journal: Thyroid : official journal of the American Thyroid Association
Published: June 20, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026